Latest news with #Mistral Iberia Real Estate
Yahoo
2 days ago
- Business
- Yahoo
European Penny Stocks To Consider In August 2025
Amidst a backdrop of strong corporate earnings and hopes for geopolitical resolutions, the pan-European STOXX Europe 600 Index has seen a notable rise, reflecting investor confidence in the region's market resilience. For investors exploring opportunities beyond well-known names, penny stocks—typically smaller or newer companies—remain an intriguing option. While the term may seem outdated, these stocks can still offer surprising value and potential growth when backed by solid financials. Top 10 Penny Stocks In Europe Name Share Price Market Cap Financial Health Rating Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.05 €22.87M ★★★★★☆ Maps (BIT:MAPS) €3.34 €44.36M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ Angler Gaming (DB:0QM) €0.37 €299.94M ★★★★★★ Cellularline (BIT:CELL) €3.12 €65.81M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.90 €18.32M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK3.255 SEK3.12B ★★★★☆☆ ForFarmers (ENXTAM:FFARM) €4.60 €406.57M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.09 €288.55M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.934 €31.5M ★★★★★★ Click here to see the full list of 336 stocks from our European Penny Stocks screener. Let's explore several standout options from the results in the screener. ABIONYX Pharma Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: ABIONYX Pharma SA is a biotech company focused on discovering and developing therapies for renal and ophthalmological diseases, with a market cap of €64.01 million. Operations: The company's revenue is primarily derived from its CRO Activity, which generated €4.55 million. Market Cap: €64.01M ABIONYX Pharma, a biotech company with a market cap of €64.01 million, is navigating challenges typical of penny stocks. Despite having more cash than debt and short-term assets exceeding liabilities, it remains pre-revenue with limited cash runway under a year. The company's revenue from CRO activities (€4.55 million) is insufficient to offset its unprofitability, as losses have increased by 18.6% annually over the past five years. While share dilution has been minimal and management is experienced, earnings are forecasted to decline by 33.8% per year for the next three years without expected profitability soon, reflecting high volatility in its stock price. Navigate through the intricacies of ABIONYX Pharma with our comprehensive balance sheet health report here. Gain insights into ABIONYX Pharma's future direction by reviewing our growth report. High Simply Wall St Financial Health Rating: ★★★★★★ Overview: High Co. SA offers consumer engagement chain solutions in France, Belgium, and Spain with a market cap of €91.99 million. Operations: The company generates revenue of €146.38 million from its advertising segment. Market Cap: €92M High Co. SA, with a market cap of €91.99 million, demonstrates financial stability as its short-term assets exceed both short and long-term liabilities, and it has more cash than total debt. Despite high-quality earnings and no significant shareholder dilution recently, the company faces challenges such as negative earnings growth over the past year and declining profit margins. Although its debt is well covered by operating cash flow, the return on equity remains low at 9.7%. Earnings are expected to decline by an average of 13.9% annually over the next three years, indicating potential volatility in stock performance. Take a closer look at High's potential here in our financial health report. Explore High's analyst forecasts in our growth report. Kudelski Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kudelski SA, along with its subsidiaries, offers digital access and security solutions for digital television and interactive applications across various countries including Switzerland, the United States, France, Germany, and Austria; it has a market cap of CHF81.37 million. Operations: The company's revenue is derived from three main segments: Digital TV, generating $227.83 million; Cybersecurity, contributing $108.47 million; and the Internet of Things, accounting for $47.43 million. Market Cap: CHF81.37M Kudelski SA, with a market cap of CHF81.37 million, is currently unprofitable but offers promising growth prospects in the digital access and security sectors. The company's strategic alliances, such as its partnership with Broadpeak to enhance streaming security for live sports content, highlight its focus on innovation and revenue protection. Despite past losses increasing at 20.3% per year over five years, Kudelski has improved its debt profile significantly from a 117% to 1.9% debt-to-equity ratio and maintains sufficient cash runway for over a year. Its seasoned management team further strengthens its potential for future stability and growth. Click to explore a detailed breakdown of our findings in Kudelski's financial health report. Understand Kudelski's earnings outlook by examining our growth report. Summing It All Up Dive into all 336 of the European Penny Stocks we have identified here. Ready For A Different Approach? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:ABNX ENXTPA:HCO and SWX:KUD. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
05-08-2025
- Business
- Yahoo
ELES Semiconductor Equipment Leads These 3 European Penny Stocks
Amid a backdrop of mixed economic signals, the European market has seen its major stock indexes decline, with the STOXX Europe 600 Index down by 2.57% due to trade deal disappointments and fluctuating economic indicators. This environment presents both challenges and opportunities for investors, particularly in niche areas like penny stocks. While often overlooked, these smaller or newer companies can offer unique growth potential when supported by strong financials and solid fundamentals. Top 10 Penny Stocks In Europe Name Share Price Market Cap Financial Health Rating Mistral Iberia Real Estate SOCIMI (BME:YMIB) €0.91 €19.82M ★★★★★☆ Lucisano Media Group (BIT:LMG) €0.97 €14.41M ★★★★☆☆ Maps (BIT:MAPS) €3.45 €45.82M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ Angler Gaming (DB:0QM) €0.37 €305.19M ★★★★★★ Cellularline (BIT:CELL) €2.94 €62.01M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.99 €18.66M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK3.255 SEK3.12B ★★★★☆☆ Deceuninck (ENXTBR:DECB) €2.20 €303.74M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.944 €31.84M ★★★★★★ Click here to see the full list of 336 stocks from our European Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. ELES Semiconductor Equipment Simply Wall St Financial Health Rating: ★★★★★★ Overview: ELES Semiconductor Equipment S.p.A. designs, manufactures, and sells test equipment, fixtures, solutions, and services for the semiconductor industry both in Italy and internationally, with a market cap of €40 million. Operations: The company's revenue is derived entirely from its Semiconductor Equipment and Services segment, totaling €35.73 million. Market Cap: €40M ELES Semiconductor Equipment, with a market cap of €40 million, has shown robust financial health as its short-term assets exceed both short and long-term liabilities. Despite a historically volatile share price, ELES's earnings grew by 55.6% last year, outpacing the broader semiconductor industry. The company's debt is well managed with operating cash flow covering 41.2% of its debt and interest payments adequately covered by EBIT. Recent developments include Mare Engineering Group's hostile bid to acquire a significant stake in ELES, potentially influencing future shareholder dynamics and strategic direction amidst ongoing growth prospects. Dive into the specifics of ELES Semiconductor Equipment here with our thorough balance sheet health report. Assess ELES Semiconductor Equipment's future earnings estimates with our detailed growth reports. Pattern Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Pattern S.p.A., along with its subsidiaries, specializes in the engineering and production of luxury goods across Italy, the rest of the European Union, and internationally, with a market cap of €61.43 million. Operations: No revenue segments have been reported for this company. Market Cap: €61.43M Pattern S.p.A., with a market cap of €61.43 million, demonstrates financial stability as its short-term assets (€65.3M) surpass both short (€45.0M) and long-term liabilities (€32.7M). However, despite high-quality earnings, the company experienced significant negative earnings growth (-98.3%) last year compared to the luxury industry average (-13.1%), leading to lower current net profit margins (0.3%). While trading below estimated fair value and forecasted for 19.78% annual earnings growth, challenges include low return on equity (0.8%) and insufficient EBIT coverage of interest payments (1.3x), though debt is well covered by operating cash flow (31.4%). Jump into the full analysis health report here for a deeper understanding of Pattern. Learn about Pattern's future growth trajectory here. Lhyfe Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Lhyfe SA produces and supplies renewable green hydrogen for mobility and industry markets, with a market cap of €155.36 million. Operations: The company generates revenue from its Oil & Gas - Exploration & Production segment, amounting to €5.10 million. Market Cap: €155.36M Lhyfe SA, with a market cap of €155.36 million, is navigating the renewable energy sector despite being unprofitable and having negative return on equity (-40.72%). The company recently raised €2.5 million through crowdfunding, bolstering its cash position which already exceeds its total debt. Lhyfe's short-term assets (€95.8M) cover short-term liabilities (€51.4M), but not long-term liabilities (€99.4M). Although losses have increased by 32.6% annually over five years, earnings are forecast to grow 44.58% per year moving forward, supported by a stable cash runway of over a year if free cash flow trends persist. Unlock comprehensive insights into our analysis of Lhyfe stock in this financial health report. Understand Lhyfe's earnings outlook by examining our growth report. Summing It All Up Unlock our comprehensive list of 336 European Penny Stocks by clicking here. Searching for a Fresh Perspective? The latest GPUs need a type of rare earth metal called Neodymium and there are only 25 companies in the world exploring or producing it. Find the list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:ELES BIT:PTR and ENXTPA:LHYFE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
